Medical Journal Club with Dr. Takuji Shirasawa

Prioritize autoimmune diseases and genetic factors.Provide the clinical indicators necessary for differentiation from secondary adrenal insufficiency.Clearly explain the precautions for patients currently undergoing steroid therapy.Describe the emergency signs that suggest an adrenal crisis and the appropriate responses.Briefly explain the differences in pathophysiology between primary and secondary adrenal insufficiency.Propose specific disease examples and diagnostic procedures frequently encountered in actual outpatient practice.

1. The importance of digitizing theknowledge of Japanese experts The biggest bottleneck in raising premium beefcattle in China is the severe shortage of human experts who systematicallyunderstand the entire lifecycle of breeds like Angus and Wagyu. By digitizingthe tacit knowledge and 50 years of experience of Japanese experts like Mr.Kinjo, the system creates a computable, replicable, and scalable "digitaltwin consultant". This allows ordinary farm managers to achieve over 80%of a top expert's skill level through AI assistance, effectively solving theindustry's critical human resource disconnect and removing the reliance onindividual "cattlemen".2. Future market expansion and revenuestructure The target market in China alone consists of 3 to 5 million premiumbeef cattle, a number that is rapidly growing. Assuming a 20-30% penetrationrate (approximately 1 million cattle), the business model involves a one-timehardware revenue (AI collars, sensors) of about 1,000 RMB per cow, totaling 1billion RMB. More importantly, the annual SaaS fee is estimated at 500-800 RMBper cow, generating a potential recurring revenue of 600 million RMB annually. Inthe mid-term (3-5 years), the goal is to reach a valuation of $5-10 billion. Inthe long term, the system aims to become the data infrastructure for the entirebeef industry, expanding into breeding, finance, and meat processing to achievea market capitalization comparable to top AgTech companies.3. The decisive technological differencesbetween this system and existing tools like Halter While Halter is valued at $2billion, it is primarily a "pasture management tool" for dairy cowsthat solves basic issues like location tracking, movement, and estrusdetection. In contrast, this system focuses on individual cattle precisiondiagnosis and nutritional management for beef cattle, solving problems that aremore than five times as complex. The AI system covers areas Halter does not,such as dynamic feed and nutrition adjustment, precise disease diagnosis,comprehensive reproductive lifecycle management, and meat quality prediction.Ultimately, Halter is merely a herd management tool, whereas this system servesas a direct substitute for a human expert, justifying a significantly highervaluation.4. Unique data assets and competitive advantages that investorsshould pay attention to The system possesses a strong data barrier built on the"expert IP"—the unreplicable 50-year experience of Japanese experts.Gathering this scenario-based decision-making data requires deep collaborationand trust, making it impossible for competitors to replicate quickly.Furthermore, the system benefits from a data 

Charcot-Marie-Tooth (CMT) neuropathy is one of the most common neuromuscular disorders. Despite the identification of more than 100 causative genes, there are few therapeuticoptions are still missing. We present the case of a 66-yeayear-old man carrying a CMT mutation in the connexin 32 gene andwith the APOE genotype ε4/ε3, has symptom who hadhad exhibited symptoms of slowly progressive muscle weakness and atrophy in the hands and feet and recently developed memory impairment.　 The symptomsymptoms of muscle weakness, motor dysfunctions, and memory impairment symptoms were significantly improved by cytokine-induced neurogenesis combined with physical wave therapy by with Arbitrary Waveform Generator (AWG). We discuss here an arbitrary waveform generator (AWG). Here, we discuss the possible mechanistic basis of how this new treatment ameliorates the symptomsymptoms of CMT and propose the a novel clinical application for the treatment ofstrategy for CMT

Alzheimer’s disease (AD) is a progressive neurodegenerative disease for which no curative treatment has yet been established. We applied cytokine-induced neurogenesis treatment to a 69-year-old female AD patient carrying APOE ε4/ε4 alleles to regenerate residual neuronal stem cells, resulting in the successful regeneration of the atrophied cerebral cortex and hippocampus associated with improved cognitive function and the resolution of electrophysiological abnormalities. To the best of our knowledge, this is the first case report demonstrating that cytokine-induced neurogenesis can reverse cognitive decline due to AD.

Background. Observational studies suggesting that immunizations strongly decrease the risk of dementia had several methodological limitations. We assessed whether common vaccines are associated with the risk of dementia.Methods. We assembled a population-based cohort of dementia-free individuals aged ≥50 years in the United Kingdom’s Clinical Practice Research Datalink between 1988 and 2018. Using a nested case-control approach, we matched each patient with dementia with 4 controls. Conditional logistic regression yielded confounder-adjusted odds ratios (ORs) with 95% confidence intervals (CIs) of dementia associated with common vaccines >2 years before the index date compared with no exposure during the study period.Moreover, we applied a 10-year lag period and used active comparators (participation in breast or prostate cancer screening) to account for detection bias.Results. Common vaccines were associated with an increasedrisk of dementia (OR, 1.38 [95% CI, 1.36–1.40]), compared with no exposure. Applying a 10-yearlag period (OR, 1.20 [95% CI, 1.18–1.23]) and comparing versus prostate cancer screening (1.19 [1.11–1.27]) but not breast cancer screening (1.37 [1.30–1.45]) attenuated the risk increase.Conclusions. Common vaccines were not associated with a decreased risk of dementia. Unmeasured confounding and detection bias likely accounted for the observed increased risk.Keywords.  epidemiology; immunization; public health; real-world evidence.

ABSTRACT Bipolar disorder (BPD), formally called manic depression, is a mental health condition that causes extreme mood swings for which specific brain pathology has not yet been precisely defined. We administered cytokine-induced neurogenesis treatment to a 60-year-old male BPD patient to regenerate GABAergic neurons as well as glutamatergic neurons, which resulted in a successful regeneration of the atrophied hippocampus and disorganized cortical structures of the prefrontal cortex and anterior cingulate cortex, which was associated with improved emotional control and the resolution of electrophysiological abnormalities. To the best of Äsl201Äslmult0 our knowledge, this is the first case report demonstrating that cytokine-induced GABAergic and glutamatergic neurogenesis repairs brain pathology due to BPD and improves emotional control. 

This Audio Clip present the cytokines, IL-10 and HGF, can be applied for the treatment of Ulcerative Colitis.